focus -WSS

focus

author：comprehensive 2025-10-01 13:59:11 - browse：17111

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

WSS

NIH launches clinical trials and new research office for long Covid

Cue Health's Covid

5 important ways Henrietta Lacks changed medical science

Melinda French Gates resigns from Gates Foundation

MultiPlan and major insurers sued for alleged medical price

What the US credit downgrade means for the economy, your finances

hotspot

focus

Sponsor introduction

Featured speakers

Sponsored By

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

What to expect as Trump is arraigned on his Jan 6. indictment

Moonlake's readout produced a cash windfall. Risks remain

What the US credit downgrade means for the economy, your finances

Heart attack and stroke risk calculators need revising

Amazon expands telehealth clinic nationwide

Tori Bowie and the unacceptable rates of Black maternal death

Vertex non

Medicare details structure of new drug price negotiation program

Cell therapy fails to slow type 1 diabetes, but safety is established

entertainment

Bird flu outbreak in cows is latest avian flu curveball

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

MultiPlan and major insurers sued for alleged medical price

Melinda French Gates resigns from Gates Foundation

Cell therapy fails to slow type 1 diabetes, but safety is established

Element Biosciences CEO lays out genome sequencing strategy

Wikipedia

hotspot

hotspot

Wikipedia